相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
Chenglong Chen et al.
CANCER LETTERS (2021)
Imaging CAR T-cell kinetics in solid tumors: Translational implications
Matthew S. Skovgard et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy
Dongli Cai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
Alba Rodriguez-Garcia et al.
FRONTIERS IN IMMUNOLOGY (2020)
Preclinical Development of MGC018, a Duocarmycin-based Antibody-drug Conjugate Targeting B7-H3 for Solid Cancer
Juniper A. Scribner et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma
Deepak Raj et al.
GUT (2019)
Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric Malignancies
Yingjuan J. Lu et al.
FRONTIERS IN ONCOLOGY (2019)
Engineering switchable and programmable universal CARs for CAR T therapy
Delong Liu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Genome-Informed Targeted Therapy for Osteosarcoma
Leanne C. Sayles et al.
CANCER DISCOVERY (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
Tumor Antigen Escape from CAR T-cell Therapy
Robbie G. Majzner et al.
CANCER DISCOVERY (2018)
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase
Alec J. Walker et al.
MOLECULAR THERAPY (2017)
Retargeting of T lymphocytes to PSCA-or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology UniCAR
Anja Feldmann et al.
ONCOTARGET (2017)
Characterization of a switchable chimeric antigen receptor platform in a pre-clinical solid tumor model
Elham Pishali Bejestani et al.
ONCOIMMUNOLOGY (2017)
Pediatric osteosarcoma: An updated review
Shachi Jain Taran et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2017)
Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells
Lucia Fernandez et al.
CLINICAL CANCER RESEARCH (2017)
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature
Steven Seaman et al.
CANCER CELL (2017)
Versatile strategy for controlling the specificity and activity of engineered T cells
Jennifer S. Y. Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
David T. Rodgers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts
M. Cartellieri et al.
BLOOD CANCER JOURNAL (2016)
Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for Sarcomas
Adrienne H. Long et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
B7-H3 is Overexpressed in Patients Suffering Osteosarcoma and Associated with Tumor Aggressiveness and Metastasis
Ling Wang et al.
PLOS ONE (2013)
Genetically Modified T cells Targeting Interleukin-11 Receptor α-Chain Kill Human Osteosarcoma Cells and Induce the Regression of Established Osteosarcoma Lung Metastases
Gangxiong Huang et al.
CANCER RESEARCH (2012)
Redirecting Gene-Modified T Cells toward Various Cancer Types Using Tagged Antibodies
Koji Tamada et al.
CLINICAL CANCER RESEARCH (2012)
Area under the curve as a tool to measure kinetics of tumor growth in experimental animals
Fei Duan et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
Murine B7-H3 is a negative regulator of T cells
DVR Prasad et al.
JOURNAL OF IMMUNOLOGY (2004)
The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses
WK Suh et al.
NATURE IMMUNOLOGY (2003)
分享论文
